Assertio Holdings upgraded by Gabelli & Co.
$ASRT
Biotechnology: Pharmaceutical Preparations
Health Care
Gabelli & Co. upgraded Assertio Holdings from Hold to Buy
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/26/2024 | $3.00 | Buy | Maxim Group |
| 7/3/2024 | $4.00 | Buy | H.C. Wainwright |
| 11/7/2022 | $7.00 | Buy | Lake Street |
Maxim Group initiated coverage of Assertio Therapeutics with a rating of Buy and set a new price target of $3.00
H.C. Wainwright initiated coverage of Assertio Therapeutics with a rating of Buy and set a new price target of $4.00
Lake Street initiated coverage of Assertio Therapeutics with a rating of Buy and set a new price target of $7.00